25 years of statin/view from the hill top | 54616
Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

25 years of statin/view from the hill top

13th European Cardiology Conference

December 05-06, 2016 Madrid, Spain

Rajeev Agarwala

Jaswant Rai Speciality Hospital, India

Scientific Tracks Abstracts: J Clin Exp Cardiolog

Abstract :

This is a review kind of presentation featuring evolution of statins usage from total cholesterol reduction to LDL reduction Hypothesis. Its documented effects in reducing cardiovascular mortality rationalizes European view of chasing LDL numbers rather than high blanket dose of statin, an American view. It also emphasizes death of HDL manipulation era and why it failed. Pleiotropic effects are also questionable. The talk will position ezetimibe and PCSK9 in current medical practices and will also feature legacy effects of statin and progressive calcification with its usage. The presentation ends with inspiration from existing guidelines. The talk will be of immense use to clinician.

Biography :

Rajeev Agarwala obtained Doctorate of Medicine in Cardiology from GB Pant Hospital, New Delhi, India in 1990. He Chairs the Department of Cardiology at Jaswant Rai Specialty Hospital Meerut. He is an active Clinician with bulk experience in Invasive Cardiology. He holds the Limca book of record for India for implanting Free Pacemaker. He has published more than 20 papers and reviews articles in various journals and actively pursues Vascular Biology and Statinology.